Impact assessment was received by Parliament on Thursday, 14 April 2005.
Regulatory impact assessment: the Medicines (Advisory Bodies) Regulations 2005 - making amendments to the Medicines Act 1968, the Medicines for Human Use (Marketing Authorisations Etc. ) Regulations 1994 and other related legislation. 6 p. DH/MHRA. 2005.
Secondary information
- Type
- Impact assessment
- Reference
- RIA 05/113;DH
- Author
- Department of Health
- Medicines and Healthcare products Regulatory Agency
- Subjects
- Complementary medicine Licensing EU law Drugs Functions Public appointments Pharmacy Prescription drugs Monitoring Regulation Safety Limited list prescribing Committee on Safety of Medicines Veterinary Products Committee Herbal medicine British Pharmacopoeia Commission Medicines Commission Advisory Board on Registration of Homeopathic Products Commission on Human Medicines Herbal Medicines Advisory Committee
- Legislation
- European Communities Act 1972
- Medicines Act 1968
- Medicines for Human Use (Marketing Authorisations Etc) Regulations 1994
- Medicines (Advisory Bodies) Regulations 2005
- Library location
- Commons Library: RIA 05/113
- Lords Library: HINF 2005/891
Librarians' tools
- Timestamp
- 2023-11-18 15:23:21 +0000
- URI
- http://data.parliament.uk/pimsdata/ImpactAssessment/56249
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/ImpactAssessment/56249
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/ImpactAssessment/56249